414 related articles for article (PubMed ID: 23089245)
1. Cancer stem cell dynamics in tumor progression and metastasis: is the microenvironment to blame?
Fessler E; Dijkgraaf FE; De Sousa E Melo F; Medema JP
Cancer Lett; 2013 Nov; 341(1):97-104. PubMed ID: 23089245
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell niche: the place to be.
Borovski T; De Sousa E Melo F; Vermeulen L; Medema JP
Cancer Res; 2011 Feb; 71(3):634-9. PubMed ID: 21266356
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
4. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic cancer stem cells: A state or an entity?
Hermann PC; Sainz B
Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment for cancer stem cells.
Kise K; Kinugasa-Katayama Y; Takakura N
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):197-205. PubMed ID: 26362921
[TBL] [Abstract][Full Text] [Related]
7. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
9. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
10. Metastatic cancer stem cells: new molecular targets for cancer therapy.
Leirós GJ; Balañá ME
Curr Pharm Biotechnol; 2011 Nov; 12(11):1909-22. PubMed ID: 21470128
[TBL] [Abstract][Full Text] [Related]
11. Breast-cancer stem cells-beyond semantics.
Badve S; Nakshatri H
Lancet Oncol; 2012 Jan; 13(1):e43-8. PubMed ID: 22225725
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cells in solid tumors.
Ailles LE; Weissman IL
Curr Opin Biotechnol; 2007 Oct; 18(5):460-6. PubMed ID: 18023337
[TBL] [Abstract][Full Text] [Related]
13. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?
Plaks V; Kong N; Werb Z
Cell Stem Cell; 2015 Mar; 16(3):225-38. PubMed ID: 25748930
[TBL] [Abstract][Full Text] [Related]
14. Cancer-inducing niche: the force of chronic inflammation.
Afify SM; Hassan G; Seno A; Seno M
Br J Cancer; 2022 Jul; 127(2):193-201. PubMed ID: 35292758
[TBL] [Abstract][Full Text] [Related]
15. Stem Cell Plasticity and Niche Dynamics in Cancer Progression.
Picco N; Gatenby RA; Anderson ARA
IEEE Trans Biomed Eng; 2017 Mar; 64(3):528-537. PubMed ID: 28113244
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
Yadav AK; Desai NS
Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
[TBL] [Abstract][Full Text] [Related]
17. Cell plasticity, senescence, and quiescence in cancer stem cells: Biological and therapeutic implications.
Paul R; Dorsey JF; Fan Y
Pharmacol Ther; 2022 Mar; 231():107985. PubMed ID: 34480963
[TBL] [Abstract][Full Text] [Related]
18. Oral Cancer Stem Cells Microenvironment.
Naik PP; Panda PK; Bhutia SK
Adv Exp Med Biol; 2017; 1041():207-233. PubMed ID: 29204835
[TBL] [Abstract][Full Text] [Related]
19. Functional and Molecular Characters of Cancer Stem Cells Through Development to Establishment.
Afify SM; Hassan G; Ishii H; Monzur S; Nawara HM; Osman A; Abu Quora HA; Sheta M; Zahra MH; Seno A; Seno M
Adv Exp Med Biol; 2022; 1393():83-101. PubMed ID: 36587303
[TBL] [Abstract][Full Text] [Related]
20. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.
López de Andrés J; Griñán-Lisón C; Jiménez G; Marchal JA
J Hematol Oncol; 2020 Oct; 13(1):136. PubMed ID: 33059744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
